1Department of Neurosurgery, University of New Mexico Hospital, Albuquerque.
2Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Albuquerque, New Mexico.
Neurosurg Focus. 2023 Mar;54(3):E6. doi: 10.3171/2022.12.FOCUS22629.
When indicated, patients with symptomatic Chiari malformation type I (CM-I) may benefit from suboccipital decompression (SOD). Although SOD is considered a lower-risk neurosurgical procedure, preoperative risk assessment and careful surgical patient selection remain critical. The objectives of the present study were twofold: 1) describe 30-day SOD outcomes for CM patients with attention to the impact of preoperative frailty and 2) design a predictive model for the primary endpoint of nonhome discharge (NHD).
There were 1015 CM-I patients who underwent SOD in the 2011-2020 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database, as specified by diagnostic and procedural codes (Current Procedural Terminology code 61343). Descriptive statistics were used to analyze total cohort baseline demographics, preoperative comorbidities, and postoperative outcomes within 30 days of surgery. Univariate cross-tabulation was used to compare baseline demographics and preoperative characteristics across the NHD and home discharge (HD) cohorts. Receiver operating characteristic (ROC) curve analysis was used to assess the discriminative ability of the revised Risk Analysis Index (RAI-rev) on NHD.
The study cohort had a median age of 36 years, and 80.6% of patients were female. Race distribution was categorized as White (69.9%), Black (16.6%), and other groups (13.6%). The most common preoperative comorbidities were active smoking (24.4%), hypertension (19.2%), and diabetes mellitus (4.7%). The primary outcome of NHD occurred in 4.6% of patients (n = 47). Increasing frailty (measured by the RAI-rev) was associated with a stepwise increase in the rate of NHD: 2.3% for RAI-rev scores 0-10, 5.8% for RAI-rev scores 11-15, 7.6% for RAI-rev scores 16-20, 18.2% for RAI-rev scores 21-25, and 77.8% for RAI-rev scores ≥ 26 (p < 0.001). Other preoperative factors associated with NHD included older age, nonelective surgery, diabetes, hypertension, and elevated creatinine (all p < 0.01). The other most common 30-day complications included unplanned readmission (9.3%), unplanned reoperation (5.3%), return to the operating room (5.8%), Clavien-Dindo grade IV (life-threatening) (1.5%), organ space surgical site infection (SSI) (1.5%), superficial SSI (1.4%), and reoperation for a CSF leak (1.1%). Surgical mortality (within 30 days) was extremely rare (1/1015, 0.1%). ROC curve analysis demonstrated that RAI-rev predicted NHD with significant discriminatory accuracy among CM-I patients who received SOD treatment (C-statistic 0.731, 95% CI 0.648-0.814).
This decade-long analysis of a multicenter surgical registry provides internationally representative, modern rates of 30-day outcomes after suboccipital decompression (with or without duraplasty) for adult CM-I patients. Preoperative frailty assessment with the RAI-rev may help identify higher-risk surgical candidates.
对于有症状的 Chiari 畸形 I 型(CM-I)患者,在适应证范围内行颅后窝减压术(SOD)可能有益。尽管 SOD 被认为是一种低风险的神经外科手术,但术前风险评估和仔细的手术患者选择仍然至关重要。本研究的目的有两个:1)描述 CM 患者 SOD 的 30 天结局,重点关注术前脆弱性的影响;2)设计非家庭出院(NHD)主要终点的预测模型。
在 2011 年至 2020 年美国外科医师学会国家手术质量改进计划(ACS NSQIP)数据库中,有 1015 例 CM-I 患者接受了 SOD,符合诊断和手术代码(当前手术术语代码 61343)的规定。使用描述性统计来分析总队列的基线人口统计学、术前合并症和手术 30 天内的术后结局。使用单变量交叉表比较 NHD 和家庭出院(HD)队列的基线人口统计学和术前特征。使用受试者工作特征(ROC)曲线分析评估修订后的风险分析指数(RAI-rev)对 NHD 的区分能力。
研究队列的中位年龄为 36 岁,80.6%的患者为女性。种族分布为白人(69.9%)、黑人(16.6%)和其他群体(13.6%)。最常见的术前合并症是主动吸烟(24.4%)、高血压(19.2%)和糖尿病(4.7%)。主要结局为 NHD,发生率为 4.6%(n=47)。脆弱性增加(用 RAI-rev 测量)与 NHD 发生率呈逐步增加的趋势:RAI-rev 评分 0-10 为 2.3%,RAI-rev 评分 11-15 为 5.8%,RAI-rev 评分 16-20 为 7.6%,RAI-rev 评分 21-25 为 18.2%,RAI-rev 评分≥26 为 77.8%(p<0.001)。与 NHD 相关的其他术前因素包括年龄较大、非择期手术、糖尿病、高血压和肌酐升高(均 p<0.01)。其他常见的 30 天并发症包括计划性再入院(9.3%)、计划性再次手术(5.3%)、返回手术室(5.8%)、Clavien-Dindo 分级 IV(危及生命)(1.5%)、器官间隙手术部位感染(SSI)(1.5%)、浅表 SSI(1.4%)和脑脊液漏再手术(1.1%)。30 天内手术死亡率(极罕见)为 1/1015(0.1%)。ROC 曲线分析表明,RAI-rev 对接受 SOD 治疗的 CM-I 患者的 NHD 具有显著的预测准确性(C 统计量为 0.731,95%CI 为 0.648-0.814)。
这项长达十年的多中心手术登记处分析提供了具有国际代表性的现代成人 Chiari 畸形 I 型患者行颅后窝减压术(伴或不伴硬脑膜成形术)后 30 天结局的资料。使用 RAI-rev 进行术前脆弱性评估可能有助于识别高风险手术患者。